-
Mashup Score: 2PLEASE DISTRIBUTE - FDA Oncology Center of Excellence Project Community January 2024 Newsletter - 11 month(s) ago
Welcome to the January 2024 edition of the FDA Oncology Center of Excellence (OCE) quarterly newsletter from Project Community. This newsletter provides a summary of OCE upcoming free public events and educational opportunities, and recent oncology product approvals. Happy New Year! At OCE we wrapped up another year of cancer drug development and are planning for even greater engagement this year. Many of you provided positive feedback on the Conversations on Cancer collaboration with the European
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2PLEASE DISTRIBUTE - FDA Oncology Center of Excellence Project Community January 2024 Newsletter - 12 month(s) ago
Welcome to the January 2024 edition of the FDA Oncology Center of Excellence (OCE) quarterly newsletter from Project Community. This newsletter provides a summary of OCE upcoming free public events and educational opportunities, and recent oncology product approvals. Happy New Year! At OCE we wrapped up another year of cancer drug development and are planning for even greater engagement this year. Many of you provided positive feedback on the Conversations on Cancer collaboration with the European
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet-
Check out the latest issue of OCE ENGAGE Project Community newsletter for patients w/ cancer, advocates, families & healthcare professionals. Featuring upcoming events, advocate and FDA staff profiles and more! https://t.co/gjE2PcPbEV #OCEProjectCommunity #ConversationsOnCancer https://t.co/7rFIRM67sZ
-
-
Mashup Score: 2PLEASE DISTRIBUTE - FDA Oncology Center of Excellence Project Community January 2024 Newsletter - 12 month(s) ago
Welcome to the January 2024 edition of the FDA Oncology Center of Excellence (OCE) quarterly newsletter from Project Community. This newsletter provides a summary of OCE upcoming free public events and educational opportunities, and recent oncology product approvals. Happy New Year! At OCE we wrapped up another year of cancer drug development and are planning for even greater engagement this year. Many of you provided positive feedback on the Conversations on Cancer collaboration with the European
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet-
Check out the latest issue of OCE ENGAGE Project Community newsletter for patients w/ cancer, advocates, families & healthcare professionals. Featuring upcoming events, advocate and FDA staff profiles and more! https://t.co/gjE2PcPbEV #OCEProjectCommunity #ConversationsOnCancer https://t.co/7rFIRM67sZ
-
-
Mashup Score: 9
On September 13, 2023, State Surgeon General Dr. Joseph A. Ladapo provided guidance against COVID-19 boosters for individuals under 65 and younger. In addition to aforementioned concerns, providers and patients should be aware of outstanding safety and efficacy concerns outlined in the State Surgeon General’s previous booster guidance released in September.
Source: content.govdelivery.comCategories: General Medicine News, Partners & KOLsTweet-
Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines https://t.co/pTCHiDVzhx
-
-
Mashup Score: 2960
On September 13, 2023, State Surgeon General Dr. Joseph A. Ladapo provided guidance against COVID-19 boosters for individuals under 65 and younger. In addition to aforementioned concerns, providers and patients should be aware of outstanding safety and efficacy concerns outlined in the State Surgeon General’s previous booster guidance released in September.
Source: content.govdelivery.comCategories: General Medicine News, Expert PicksTweet-
As always, Florida will put scientific integrity and the safety of our citizens above profit-fueled agendas. See my full recommendation here: https://t.co/PkonLzaCUL
-
-
Mashup Score: 13Top Cancer Currents Stories of 2023 - 1 year(s) ago
Dear Cancer Currents subscriber, As we approach the end of another year, we find ourselves reflecting on the fact that modern-day cancer research is as diverse as it is remarkable. Researchers continue to develop innovative ways to exploit weaknesses in cancer cells; make surgery and radiation more precise and effective; understand cancer’s effects on the physical, mental, and financial well-being of those with the disease and their loved ones—and much, much more. Our top stories of the year capture some
Source: content.govdelivery.comCategories: General Medicine News, Hem/OncsTweet-
Top Cancer Currents Stories of 2023 From @theNCI https://t.co/xLbs8NJiMa
-
-
Mashup Score: 4
The Panel on Antiretroviral Therapy and Medical Management of Children Living wit h HIV (the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise and current engagement in the clinical use of antiretrovirals in infants and children, including in neonates and infants exposed to HIV. Individuals who served as Panel members in the past are welcome to reapply. Panel members critically evaluate new information and
Source: content.govdelivery.comCategories: General Medicine News, Infectious DiseaseTweet-
The HHS Panel on Guidelines for Use of Antiretroviral Agents in Pediatric HIV Infection is Accepting Nominations for new Scientific/Clinical Members https://t.co/0l3zRopzCB
-
-
Mashup Score: 2OCE PULSE - Happy Thanksgiving From FDA Oncology! - 1 year(s) ago
As we move from Thanksgiving into the winter holidays, consider using some down time to learn about four oncology drug approvals in November. Or join us Nov. 30 (or later on demand) for what promises to be a “blockbuster” Conversations on Cancer discussion on drug development. See below for more news, events and training opportunities in this edition, and we invite you to get to know one of our FDA oncologists. February 22, 2024: FDA-IMS Joint Workshop: Defining Patient Populations for Clinical Trials
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet-
The December issue of the OCE PULSE has posted! Check it out for updates on oncology/hematology drug approvals, public events and professional training opportunities. https://t.co/Qy7J1NnU79 #OCEProjectSocrates #MedEd #OCEPULSE https://t.co/7bxIqE8W2u
-
-
Mashup Score: 2OCE PULSE - Happy Thanksgiving From FDA Oncology! - 1 year(s) ago
As we move from Thanksgiving into the winter holidays, consider using some down time to learn about four oncology drug approvals in November. Or join us Nov. 30 (or later on demand) for what promises to be a “blockbuster” Conversations on Cancer discussion on drug development. See below for more news, events and training opportunities in this edition, and we invite you to get to know one of our FDA oncologists. February 22, 2024: FDA-IMS Joint Workshop: Defining Patient Populations for Clinical Trials
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet-
The December issue of the OCE PULSE has posted! Check it out for updates on oncology/hematology drug approvals, public events and professional training opportunities. https://t.co/Qy7J1NnU79 #OCEProjectSocrates #MedEd #OCEPULSE https://t.co/7bxIqE8W2u
-
-
Mashup Score: 1075Florida’s Public Health Integrity Committee Addresses FDA’s Inconsistent Drug Approval and Advertising Protocols - 1 year(s) ago
Tallahassee, Fla. – Yesterday, Florida’s Public Health Integrity Committee (PHIC), led by State Surgeon General Dr. Joseph A. Ladapo, held a meeting to discuss potential harms of the United States Food and Drug Administration’s (FDA) inconsistent process for drug approval and lack of regulation of pharmaceutical advertising. Florida’s PHIC members expressed concerns regarding the revolving door between the FDA and the pharmaceutical industry, the FDA’s inadequate safety standards, and the lack of
Source: content.govdelivery.comCategories: General Medicine News, Expert PicksTweet-
Last week, I met with Florida’s Public Health Integrity Committee to discuss potential harms of @US_FDA's inconsistent process for drug approval and lack of regulation of pharmaceutical advertising. Full press release: https://t.co/Zari6hqPk1 https://t.co/mWfFCVDAZ8
-
Check out the latest issue of OCE ENGAGE Project Community newsletter for patients w/ cancer, advocates, families & healthcare professionals. Featuring upcoming events, advocate and FDA staff profiles and more! https://t.co/gjE2PcPbEV #OCEProjectCommunity #ConversationsOnCancer https://t.co/7rFIRM67sZ